About
VLX Ventures invests in early-stage startups led by exceptional entrepreneurs. VLX's sweet spot are data-driven, biotechnology and pharma companies, as well as digital pharma, utilizing notions from two or more of these domains. VLX's seed investments ($700K-$1M) are performed via its technological incubator in Jerusalem. It does follow-on investments. VLX's highly versatile and experienced team provides entrepreneurs with extensive mentoring and networking support. Its experience and know-how, combined with its financial backing and administrative assistance, give early-stage startups all the tools they need to grow and thrive. VLXs major shareholder, CBG Asset Management, has a holistic investment approach and is driven by deep analysis of worldwide trends and global dynamics. It has invested ~300m USD in Israel in several leading funds, incubators and companies and is continuing to develop its professional, strong ecosystem.CBGs diversified portfolio includes areas such as Life Sciences, Digital Health, AI, Data Science & Computer Vision. VLX's other shareholders are Van Leer Technology Ventures Jerusalem and Xenia Venture Capital.